← Back to search
HENNEPIN HEALTHCARE RESEARCH INSTITUTE
MINNEAPOLIS, MN, 55415
Unclaimed
Prime contracting experience
5 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | MAINTENANCE AND UPDATE OF THE UNITED STATES RENAL DATA SYSTEM (USRDS) | — | $9,629,120 | Sep 29, 2026 | Jun 8, 2019 – Mar 7, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | NEW COST-REIMBURSEMENT CONTRACT AWARD FOR THE PROCUREMENT OF SUPPORT SERVICES FOR THE MAINTENANCE AND UPDATE THE USRDS. | — | $8,783,144 | Aug 18, 2026 | Mar 8, 2024 – Mar 7, 2027 |
| Prime | Department of Health and Human Services Health Resources and Services Administration | HSB115 C 7180 SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENT (SRTR) BRIDGE CONTRACT | — | $5,961,463 | Jul 10, 2026 | Mar 21, 2026 – Dec 20, 2026 |
| Prime | Department of Health and Human Services Health Resources and Services Administration | THE HEALTH RESOURCES AND SERVICES ADMINISTRATION (HRSA) IS SEEKING A CONTRACTOR TO OPERATE THE SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR). THE CONTRACTOR WILL BE RESPONSIBLE FOR PROVIDING STATISTICAL AND OTHER ANALYTIC SUPPORT TO THE ORGAN P | — | $37,496,380 | Sep 25, 2025 | Sep 21, 2020 – Mar 20, 2026 |
| Prime | Department of Health and Human Services Health Resources and Services Administration | IGF::OT::IGF SCIENTIFIC REGISTRY OF TRANSPLANT RECIPENTS (SRTR) | — | $27,247,110 | Jun 25, 2024 | Sep 21, 2015 – Sep 20, 2020 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
11 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | DURING THE BASE PERIOD OF THIS CONTRACT, HHRI WILL PROVIDE CONSULTATION AND SUPPORT FOR ACTIVITIES AND DELIVERABLES DESCRIBED IN THE CMS SOW. WE NEXT DESCRIBE SPECIFIC ACTIVITIES AND DELIVERABLES FOR ALL RELEVANT TASKS. EACH TASK SPECIFIED BY CMS SHALL INCLUDE ONE OR MORE SUBTASKS TO ACCOMPLISH THE EVALUATION OF THE INCREASING ORGAN ACCESS TRANSPLANT (IOTA) MODEL (IOTA EVALUATION) PROGRAM EFFORTS. WE LIST SPECIFIC DELIVERABLES AND ACTIVITIES FOR HHRI TO PROVIDE CONSULTATION AND TECHNICAL INPUT, AND MAY REQUEST ADDITIONAL SUPPORT, AS NECESSARY. 0825100001 Parent award context Parent award agency: Department of Health and Human Services · Centers for Medicare and Medicaid Services Parent award NAICS: 541720 Parent award performance state: VA Parent award description: THE PURPOSE OF THE TASK ORDER IS TO OBTAIN CONTRACTOR SERVICES TO CONDUCT AN INDEPENDENT EVALUATION OF THE INCREASING ORGAN ACCESS TRANSPLANT (IOTA) MODEL. THE TASK ORDER WILL ASSESS THE MODEL'S EFFECT ON THE DELIVERY OF KIDNEY TRANSPLANTS, DISCARD O View parent award on USAspending | 75FCMC19D0082USAspending | $155,020 | Sep 22, 2026 | — – — |
| Subcontractor | Department of Defense | NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL AWD00006474-1 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541712 Parent award performance state: PA Parent award description: NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL View parent award on USAspending | W81XWH16D0024USAspending | $620,200 | Sep 12, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | THE PURPOSE OF STUDIES AT THE HENNEPIN HEALTHCARE RESEARCH INSTITUTE (HHRI) SITE IS TO
TEST LEAD VACCINES TARGETING HEROIN AND FENTANYL FOR THEIR ABILITY TO REDUCE THE ADDICTIVE
EFFECTS OF THESE DRUGS IN RATS. IN ADDITION, HHRI WILL EXAMINE WHETHER COMBINING THESE
VACCINES INTO A BIVALENT FORMULATION WILL ALTER THEIR EFFICACY. THE WORK REQUIRED TO
ACCOMPLISH THIS INVOLVES A SERIES OF FIVE STUDIES IN WHICH THE EFFECTS OF VACCINATION ON
HEROIN AND FENTANYL SELF-ADMINISTRATION AND WITHDRAWAL WILL BE EXAMINED IN RATS. THE FIRST
EXPERIMENT WILL TEST THE EFFICACY OF A LEAD HEROIN AND BIVALENT VACCINE AT REDUCING HEROIN
SELF-ADMINISTRATION (HSA). THE SECOND EXPERIMENT WILL TEST THE EFFICACY OF A LEAD FENTANYL
AND BIVALENT VACCINE AT REDUCING FENTANYL SELF-ADMINISTRATION (FSA). THE THIRD
EXPERIMENT WILL TEST THE EFFICACY OF THE BIVALENT VACCINE AT REDUCING COCAINE SELFADMINISTRATION
TO CONFIRM THE BEHAVIORAL SPECIFICITY OF THE VACCINE. THE FOURTH AND FIFTH
EXPERIMENTS WILL TEST WHETHER THE BIVALENT VACCINE PRECIPITATES HEROIN OR FENTANYL
WITHDRAWAL, RESPECTIVELY, USING AN INTRACRANIAL SELF-STIMULATION ASSAY. PG21-61170-02/PG25-61316-02 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: MT Parent award description: TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL. View parent award on USAspending | — | $1,046,866 | Apr 18, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 105650 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $535,000 | Jul 22, 2024 | — – — |
| Subcontractor | Department of Defense | THE AIMS OF THE CALCIUM AND VASOPRESSIN POST-INJURY EARLY RESUSCITATION (CAVALIER) TRIAL ARE TO DETERMINE THE SAFETY AND EFFICACY OF PREHOSPITAL
CALCIUM SUPPLEMENTATION AND EARLY IN-HOSPITAL VASOPRESSIN INFUSION AS COMPARED TO STANDARD CARE RESUSCITATION IN PATIENTS AT RISK OF HEMORRHAGIC
SHOCK AND TO APPROPRIATELY CHARACTERIZE ANY ADDITIVE EFFECT OF BOTH RESUSCITATION ADJUNCT INTERVENTIONS. CAVALIER'S PRIMARY STUDY OBJECTIVE IS TO
DETERMINE WHETHER PREHOSPITAL CALCIUM, EARLY IN-HOSPITAL VASOPRESSIN, OR BOTH AS COMPARED TO PLACEBO RESULTS IN LOWER 30-DAY MORTALITY IN
PATIENTS AT RISK OF HEMORRHAGIC SHOCK. SECONDARY STUDY OBJECTIVES INCLUDE DETERMINING WHETHER THE INTERVENTIONS ARE ASSOCIATED WITH MORTALITY
OUTCOMES (6-HOUR, 24-HOUR, IN-HOSPITAL, DEATH FROM HEMORRHAGE AND BRAIN INJURY), BLOOD AND BLOOD COMPONENT TRANSFUSION REQUIREMENTS (6-
HOUR AND 24-HOUR), INCIDENCE OF MULTIPLE ORGAN FAILURE (MOF), INCIDENCE OF NOSOCOMIAL INFECTION, TIME TO HEMOSTASIS, INCIDENCE OF COAGULOPATHY
BY THROMBOELASTOGRAPHY (TEG), AND ICU-FREE AND HOSPITAL-FREE DAYS. AWD00006474-1 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541712 Parent award performance state: PA Parent award description: NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL View parent award on USAspending | W81XWH16D0024USAspending | $500,000 | Oct 27, 2023 | — – — |
| Subcontractor | Department of Defense | THE AIMS OF THE CALCIUM AND VASOPRESSIN POST-INJURY EARLY RESUSCITATION (CAVALIER) TRIAL ARE TO DETERMINE THE SAFETY AND EFFICACY OF PREHOSPITAL
CALCIUM SUPPLEMENTATION AND EARLY IN-HOSPITAL VASOPRESSIN INFUSION AS COMPARED TO STANDARD CARE RESUSCITATION IN PATIENTS AT RISK OF HEMORRHAGIC
SHOCK AND TO APPROPRIATELY CHARACTERIZE ANY ADDITIVE EFFECT OF BOTH RESUSCITATION ADJUNCT INTERVENTIONS. CAVALIER'S PRIMARY STUDY OBJECTIVE IS TO
DETERMINE WHETHER PREHOSPITAL CALCIUM, EARLY IN-HOSPITAL VASOPRESSIN, OR BOTH AS COMPARED TO PLACEBO RESULTS IN LOWER 30-DAY MORTALITY IN
PATIENTS AT RISK OF HEMORRHAGIC SHOCK. SECONDARY STUDY OBJECTIVES INCLUDE DETERMINING WHETHER THE INTERVENTIONS ARE ASSOCIATED WITH MORTALITY
OUTCOMES (6-HOUR, 24-HOUR, IN-HOSPITAL, DEATH FROM HEMORRHAGE AND BRAIN INJURY), BLOOD AND BLOOD COMPONENT TRANSFUSION REQUIREMENTS (6-
HOUR AND 24-HOUR), INCIDENCE OF MULTIPLE ORGAN FAILURE (MOF), INCIDENCE OF NOSOCOMIAL INFECTION, TIME TO HEMOSTASIS, INCIDENCE OF COAGULOPATHY
BY THROMBOELASTOGRAPHY (TEG), AND ICU-FREE AND HOSPITAL-FREE DAYS. AWD00006474-1 Parent award context Parent award agency: Department of Defense · Defense Health Agency Parent award NAICS: 541712 Parent award performance state: PA Parent award description: NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL View parent award on USAspending | W81XWH16D0024USAspending | $500,000 | Oct 27, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 105650 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $565,000 | Aug 17, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 105650 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541715 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $580,000 | Oct 10, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | THE PURPOSE OF THIS CONTRACT IS TO EVALUATE THE EFFECTIVENESS OF VACCINES AGAINST COVID-19, INFLUENZA, AND EVENTUALLY, RSV, AMONG U.S. ADULTS WITH SEVERE ACUTE RESPIRATORY ILLNESS. THE PRIMARY AIM IS TO MONITOR EFFECTIVENESS AGAINST COVID-19-ASSOCIATED AND INFLUENZA-ASSOCIATED HOSPITALIZATIONS, INCLUDING EFFECTIVENESS AGAINST EMERGING VARIANTS OF CONCERN AND DURATION OF PROTECTION. THE CONTRACT WILL ALSO CONDUCT RSV SURVEILLANCE AMONG INPATIENTS WITH ARI AND BUILD ON PRIOR EFFORTS TO UNDERSTAND SEVERE ARI, SEVERITY SCORES, SUSCEPTIBILITY TO INFECTION, MECHANISMS OF DISEASE ATTENUATION, AND VACCINE FAILURES.
PROJECT TITLE IVY4 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 97771 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 622110 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $374,000 | May 20, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | THE PURPOSE OF THIS CONTRACT IS TO EVALUATE THE EFFECTIVENESS OF VACCINES AGAINST COVID-19, INFLUENZA, AND EVENTUALLY, RSV, AMONG U.S. ADULTS WITH SEVERE ACUTE RESPIRATORY ILLNESS. THE PRIMARY AIM IS TO MONITOR EFFECTIVENESS AGAINST COVID-19-ASSOCIATED AND INFLUENZA-ASSOCIATED HOSPITALIZATIONS, INCLUDING EFFECTIVENESS AGAINST EMERGING VARIANTS OF CONCERN AND DURATION OF PROTECTION. THE CONTRACT WILL ALSO CONDUCT RSV SURVEILLANCE AMONG INPATIENTS WITH ARI AND BUILD ON PRIOR EFFORTS TO UNDERSTAND SEVERE ARI, SEVERITY SCORES, SUSCEPTIBILITY TO INFECTION, MECHANISMS OF DISEASE ATTENUATION, AND VACCINE FAILURES.
PROJECT TITLE IVY4 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 97771 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 622110 Parent award performance state: TN Parent award description: SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2 View parent award on USAspending | — | $284,000 | Feb 14, 2022 | — – — |
| Subcontractor | Department of Health and Human Services | SITE RESPONSIBILITIES
€¢ KICKOFF MEETING (BY TELECONFERENCE)
O TWO HOURS (PI+RA+PM)
O JUSTIFICATION: REQUIRED FOR COMMUNICATION OF PROJECT GOALS AND EXPECTATION
€¢ ESTABLISHMENT OF THE SURVEILLANCE PROTOCOL AND CASE REPORT FORM INCLUDING RUDIMENTARY TEXT IDENTIFICATION FOR VACCINATION STATUS.
O JUSTIFICATION: SET-UP TIME AND EFFORT COSTS REQUIRED FOR INFORMATION TRANSFER FROM EACH SITE FOR ALL GOALS, WHICH REQUIRES FACE TO FACE MEETINGS, MULTIPLE ZOOM CALLS WITH THE PRIME SITE, AND MULTIPLE TEST RUNS. REQUIRED TO COMMUNICATE WITH OTHER SITES TO BALANCE FEASIBILITY AND RIGOR
€¢ ESTABLISH OR AMEND AGREEMENTS WITH EDNS INSTITUTIONAL REVIEW BOARD (IRB) NON-RESEARCH N/A
€¢ REPORT ESTIMATES OF POPULATIONS SERVED BY EACH HOSPITAL/HOSPITAL NETWORK.
O JUSTIFICATION: REQUIRES SEVERAL MEETINGS TO ESTABLISH SEARCH PARAMETERS AND REVIEW RESULTS
€¢ IRB APPROVAL OF THE SURVEILLANCE PROTOCOL.
O JUSTIFICATION: FOR ALL GOALS, EACH SITE WILL NEED TO MAINTAIN IDENTIFYING INFORMATION ON EACH PATIENT, AND THIS WILL REQUIRE FULL IRB REVIEW. DEVELOP OR MODIFY EXISTING DATA COLLECTION TOOLS AND PROTOCOLS TO SUPPORT THE DATA COLLECTION.
O JUSTIFICATION: REQUIRED TO ESTABLISH FEASIBILITY OF ENSURING COMPLIANCE WITH FEDERAL RULES ON PRIVACY, WHILE ALLOWING LOCAL IDENTIFICATION, AND ENSURING INTERNAL SYSTEMS FOR SWAB TRANSFER TO APPROPRIATE AUTHORITIES
€¢ SUBMIT DRAFT DATA MANAGEMENT PLAN
O JUSTIFICATION: TWO ONE-HOUR ZOOM CALLS TO CREATE METHODS OF API EXTRACTION, DEFINITIONS OF DATA QUALITY, METHODOLOGY FOR TRAINING OF ABSTRACTORS FOR GOAL [6], METHODS FOR REAL- TIME DATA COLLECTION IN GOAL [4], AND PROCEDURES FOR HANDLING OF MISSING DATA. WSU22009 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 541360 Parent award performance state: GA Parent award description: ENHANCING U.S. SURVEILLANCE OF LABORATORY CONFIRMED SARS-COV-2, INFLUENZA, AND OTHER RESPIRATORY VIRUSES View parent award on USAspending | — | $155,052 | Dec 14, 2021 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced